Morpholine and thiomorpholine tachykinin receptor antagonists
US5719147A · kind A · utility
83Cited by
15References
27Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Sep 8, 1995 |
| Grant date | Feb 17, 1998 |
| Priority date | — |
| Expiry date | Sep 8, 2015 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07D413/14
- WIPO fieldOrganic fine chemistry
- WIPO sectorChemistry
Abstract
Substituted heterocycles of the general structural formula: ##STR1## are tachykinin receptor antagonists useful in the treatment of inflammatory diseases, pain or migraine, asthma and emesis, and calcium channel blockers useful in the treatment of cardiovascular conditions such as angina, hypertension or ischemia.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.